A Single-Dose study of Sildenafil in Schizophrenia
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
This study has finished and is no longer accepting participants.
In Boston
Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
This study has finished and is no longer accepting participants.
In BostonA Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients
This study has finished and is no longer accepting participants.
In BostonA Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BostonA Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BostonAn Open-Label, Positron Emission Tomography (PET) Study to Evaluate the Brain 5 HT6 Receptor Occupancy by Single Doses of SLV354 in Healthy Male Subjects and Subjects With Stable Schizophrenia
This study has finished and is no longer accepting participants.
In New HavenThe "Therapeutic Window" of the "Atypical" Antipsychotic Paliperidone Extended Release (ER)-A Positron Emission Tomography Study With [18F]Fallypride as the Radiotracer
This study ended early.
In AachenA Randomized Double-Blind, Placebo-Controlled, Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BostonResearchers are studying Zolodine to find out how it affects psychotic symptoms in people with schizophrenia.
This study ended early.
Location not clearly listedEffectiveness of 6 Antipsychotic Drugs in the Treatment of Acute Exacerbations of Chronic Inpatients With Schizophrenia: a Randomized Double-blind Study
This study has finished and is no longer accepting participants.
In BeijingA Randomized, 6-week Double-blind, Parallel Study to Evaluate the Efficacy and the Safety of Flexible Doses of Extended Release OROS Paliperidone Compared With Olanzapine in the Treatment of Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingA Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia
This study ended early.
In Kaohsiung CityA Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Subjects With Stable Schizophrenia
This study has finished and is no longer accepting participants.
In LondonWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.